000 01640 a2200445 4500
005 20250512194324.0
264 0 _c19850426
008 198504s 0 0 eng d
022 _a0023-2173
024 7 _a10.1007/BF01712183
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReitz, M
245 0 0 _aCoagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.
_h[electronic resource]
260 _bKlinische Wochenschrift
_cDec 1984
300 _a1165-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aAntithrombin III
_xmetabolism
650 0 4 _aBlood Coagulation Factors
_xmetabolism
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aComplement C1 Inactivator Proteins
_xblood
650 0 4 _aFactor XIII
_xmetabolism
650 0 4 _aFemale
650 0 4 _aFibrinogen
_xmetabolism
650 0 4 _aFibronectins
_xblood
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphoid
_xdrug therapy
650 0 4 _aMale
650 0 4 _aProtease Inhibitors
_xblood
650 0 4 _aProthrombin
_xmetabolism
650 0 4 _aalpha 1-Antitrypsin
_xmetabolism
650 0 4 _aalpha-Macroglobulins
_xmetabolism
700 1 _aWitzke, G
700 1 _aEgbring, R
700 1 _aGutjahr, P
773 0 _tKlinische Wochenschrift
_gvol. 62
_gno. 24
_gp. 1165-9
856 4 0 _uhttps://doi.org/10.1007/BF01712183
_zAvailable from publisher's website
999 _c6085248
_d6085248